Want to join the conversation?
$JNJ subsidiary, Janssen Research, said The FDA has granted a fourth Breakthrough Therapy Designation for IMBRUVICA for treating patients with chronic graft-versus-host-disease (cGVHD). FDA also granted the therapy Orphan Drug Designation for cGVHD. IMBRUVICA is jointly developed and commercialized by Janssen Biotech and Pharmacyclics.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.